The customer complained of questionable elecsys rubella igg (rub igg) immunoassay results for 3 separate samples from the same patient tested on a cobas e 411 immunoassay analyzer compared to the results from the elisa igg test method.On (b)(6) 2018 sample a rub igg result from the cobas e411 was 19.13 iu/ml, reactive.On (b)(6) 2018 sample b rub igg result from the cobas e411 was 19.09 iu/ml, reactive.On (b)(6) 2018 sample c rub igg result from the cobas e411 was 16.48 iu/ml, reactive.For samples a, b, and c the elisa igg test results were negative.The erroneous results were released outside of the laboratory to both the patient and their doctor.There was no allegation of an adverse event.The patient has no medical history of rubella disease or vaccination.The cobas e411 serial number was (b)(4).It was stated that the customer rarely runs qc testing.The customer had run qc testing on (b)(6) 2018 with acceptable results.From the information provided, it appears the rub igg reagent lot used for the (b)(6) 2018 result was lot 267421, and the rub igg reagent lot used for the (b)(6) 2018 results was lot 28366401 with an expiration date of 30-sep-2018.The investigation is currently ongoing.
|